MMR deficiency, irrespective of its genetic or epigenetic origin, leads to the mutator phenotype, and FS APC mutations, predominantly in mononucleotide tracks, are more frequent in MSI tumours [36]. The gene discussed is APC; the disease is mismatch repair cancer syndrome 1.